Literature DB >> 10548827

Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel.

P D Miller1, D T Baran, J P Bilezikian, S L Greenspan, R Lindsay, B L Riggs, N B Watts.   

Abstract

Biochemical markers of bone turnover have emerged as powerful tools to aid in managing osteoporosis. The newer bone markers have been intensively studied for more than a decade. As a result, we can now confidently report their clinical utility in assessing risk of rapid bone loss and fracture, and monitoring therapy in postmenopausal women with or at risk of osteoporosis. In this review, we will provide a comprehensive foundation for this utility. While there are still questions remaining to be answered, bone marker technology has matured to play an essential role in patient management. We will describe, in practical terms, how bone markers can be appropriately incorporated into clinical practice today.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548827     DOI: 10.1385/jcd:2:3:323

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  14 in total

Review 1.  Alendronate and risedronate for the treatment of postmenopausal osteoporosis: clinical profiles of the once-weekly and once-daily dosing formulations.

Authors:  Ronald Emkey
Journal:  MedGenMed       Date:  2004-07-19

2.  Canadian Consensus Conference on osteoporosis, 2006 update.

Authors:  Jacques P Brown; Michel Fortier; Heather Frame; André Lalonde; Alexandra Papaioannou; Vyta Senikas; Chui Kin Yuen
Journal:  J Obstet Gynaecol Can       Date:  2006-02

3.  Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats.

Authors:  S Canpolat; N Tug; A D Seyran; S Kumru; B Yilmaz
Journal:  J Physiol Biochem       Date:  2010-04-29       Impact factor: 4.158

4.  Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.

Authors:  Mila P Salcedo; Anil K Sood; Anuja Jhingran; Patricia J Eifel; Ann H Klopp; Revathy B Iyer; Bryan M Fellman; Camilo Jimenez; Kathleen M Schmeler
Journal:  Cancer       Date:  2020-03-03       Impact factor: 6.860

5.  Monitoring osteoporosis therapies.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2007-03       Impact factor: 5.096

Review 6.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

7.  Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women.

Authors:  M Cifuentes; M A Johnson; R D Lewis; S B Heymsfield; H A Chowdhury; C M Modlesky; S A Shapses
Journal:  Osteoporos Int       Date:  2003-02-04       Impact factor: 4.507

Review 8.  The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review.

Authors:  L J Peppone; S Hebl; J Q Purnell; M E Reid; R N Rosier; K M Mustian; O G Palesh; A J Huston; M N Ling; G R Morrow
Journal:  Osteoporos Int       Date:  2009-12-04       Impact factor: 4.507

9.  Correlation of bone mineral density with biochemical markers in post menopausal women.

Authors:  S Agrawal; Anju Jain; D Mahajan; C Raghunandan
Journal:  Indian J Clin Biochem       Date:  2009-09-16

Review 10.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.